Trials / Unknown
UnknownNCT04130373
Multicentric Risk Evaluation of Autologous Fat Grafting Procedure
Multicentic Retrospective Evaluation of Risks in Mammary Carcinoma Relapse in Patients With Mammary Reconstruction and Autologous Fat Grafting
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 6,510 (actual)
- Sponsor
- Humanitas Clinical and Research Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Autologous fat grafting, also known as lipofilling, is a surgical technique consisting in the processing and transfer of adipose tissue from one area in our organism (hips, thighs) to region which in need of reconstructive and aesthetic correction. The technique is frequently used after radical or conservative mammary surgery, aiming to achieve better aesthetic results, reduce pain induced by both surgery and radiotherapy. The scientific community was widely involved in the debate regarding the use of mesenchymal/stem cells in a patient with high risk of tumor progression due to their elevated proliferative profile. This study aims to retrospectively evaluate the oncological safety in the use of lipofilling in patients who underwent oncological and reconstructive treatment in our Institute.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Autologous fat grafting procedure | Surgical intervention based on the injection of autologous fat grafting after radical or conservative breast surgery and breast reconstruction. |
| PROCEDURE | Breast reconstruction | Breast reconstructive procedures after oncological radical or conservative breast surgery |
Timeline
- Start date
- 2019-06-01
- Primary completion
- 2020-01-01
- Completion
- 2020-06-01
- First posted
- 2019-10-17
- Last updated
- 2019-10-30
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT04130373. Inclusion in this directory is not an endorsement.